CMAC welcomes John Mack as Tier 2 Industry Board representative
CMAC has appointed John Mack as a new member of its Industry Board. Representing CMAC’s Tier 2 membership, John’s role will enhance the Tier 2 community's connection to CMAC’s activities, ensuring the centre stays at the forefront of manufacturing advancements and continues to meet the evolving needs of its members.
John leads the APC team within the Applied Material’s APG Pharma group. He has over 20 years of experience in Machine Learning, Advanced Process Control, process modelling and optimisation, and project management, with a focus on improving efficiency and product quality.
This appointment is a strategic step in bridging academic and industrial partnerships, which are critical to CMAC’s continued growth and success.
CMAC Director, Distinguished Professor Alastair Florence, said:
"I am delighted that John has accepted this important role representing our Tier 2 partners' interests on the Industry Board. For over a decade, John has actively supported CMAC projects, driving research and technological innovation for the digital transformation of sustainable medicines manufacturing. I look forward to continuing to work together in his new role to accelerate the impact of CMAC's work in these critically important areas."
Massimo Bresciani, Industry Director at CMAC, said:
“John’s industry insights and advocacy for pre-competitive research and industry collaboration will be invaluable as CMAC continues to drive cutting-edge research and strengthen industry partnerships.”
John Mack, Head of Perceptive Advanced Process Control at Applied Materials, said:
“I reflect with a great deal of satisfaction on how Perceptive Engineering and now Applied Materials has played our small part in the CMAC journey since 2012. Equally CMAC’s support and the opportunity to demonstrate solutions pre-competitively as a Tier 2 company was key to our initial success as we set out to bring our technology to the Pharmaceutical industry. I’m delighted to represent CMAC’s Tier 2 community and look forward to the continued success of CMAC.”
Located at the University of Strathclyde, CMAC is a world- leading research centre in medicines development, manufacture and supply, dedicated to fostering a dynamic environment between academic research, cutting-edge technologies, and industrial applications. With eight Tier 1 specialty pharma members and fourteen Tier 2 members globally, close collaboration has further enhanced research potential, facilitated translation to industry, and supported the development of future workplace skills.
To find out more about CMAC’s vision and its involvement with the medicines manufacturing industry, visit www.cmac.ac.uk. To enquire about collaboration opportunities or our capabilities and services, contact Rebekah Russell, Industry Relationship Manager via email rebekah.russell@strath.ac.uk.